B7-H1 expression is upregulated in peripheral blood CD14+monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels

被引:34
作者
Geng, L. [1 ]
Jiang, G. [1 ]
Fang, Y. [1 ]
Dong, S. [1 ]
Xie, H. [1 ]
Chen, Y. [1 ]
Shen, M. [1 ]
Zheng, S. [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Minist Publ Hlth,Key Lab Combined Multiorgan Tran, Hangzhou 310003, Peoples R China
关键词
B7-H1; chronic hepatitis B virus infection; interleukin-10;
D O I
10.1111/j.1365-2893.2006.00746.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronicity in hepatitis B virus (HBV) infection is maintained by increased type 2 T-helper cell response, possibly because of increased interleukin-10 (IL-10) productions. B7-H1 can negatively regulate T-cell responses via its receptor, programmed death 1. Ligation of B7-H1 to T-cells can result in the preferential secretion of IL-10. In this study, we investigated whether there was an upregulated expression of B7-H1 in peripheral blood mononuclear cells in patients chronically infected by HBV and further explored the correlation between B7-H1 expression and serum interleukin 2, interferon-gamma, IL-10, HBeAg, alanine aminotransferase (ALT) levels and viral load. Fifty-five patients with chronic HBV infection and 20 healthy controls (HCs) were enrolled in the present study. The results showed that in patients with chronic hepatitis B CD14+ monocytes but not CD3+ and CD19+ cells had a significantly increased expression of B7-H1 compared with HCs, which positively correlates with serum IL-10 levels and the presence of HBeAg and negatively correlates with serum ALT levels. In conclusion, chronic HBV patients harbour an increased B7-H1 expression in CD14+ monocytes compared with controls, which may be responsible for the increased serum IL-10 levels. This might be an important way by which HBV evades an adequate immune response, leading to viral persistence and disease chronicity.
引用
收藏
页码:725 / 733
页数:9
相关论文
共 36 条
[21]   B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis [J].
Mazanet, MM ;
Hughes, CCW .
JOURNAL OF IMMUNOLOGY, 2002, 169 (07) :3581-3588
[22]  
McAdam AJ, 1998, IMMUNOL REV, V165, P231
[23]   Interleukin-10 and the interleukin-10 receptor [J].
Moore, KW ;
Malefyt, RD ;
Coffman, RL ;
O'Garra, A .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :683-765
[24]   PD-1: an inhibitory immunoreceptor involved in peripheral tolerance [J].
Nishimura, H ;
Honjo, T .
TRENDS IN IMMUNOLOGY, 2001, 22 (05) :265-268
[25]   Programmed death-1 targeting can promote allograft survival [J].
Özkaynak, E ;
Wang, LQ ;
Goodearl, A ;
McDonald, K ;
Qin, SX ;
O'Keefe, T ;
Duong, T ;
Smith, T ;
Gutierrez-Ramos, JC ;
Rottman, JB ;
Coyle, AJ ;
Hancock, WW .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6546-6553
[26]   Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alfa [J].
Rico, MA ;
Quiroga, JA ;
Subirá, D ;
Castañón, S ;
Esteban, JM ;
Pardo, M ;
Carreño, V .
HEPATOLOGY, 2001, 33 (01) :295-300
[27]   The role of different subsets of T regulatory cells in controlling autoimmunity [J].
Roncarolo, MG ;
Levings, MK .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (06) :676-683
[28]   Beneficial effects of 'lamivudine pulse' therapy in HBeAg-positive patients with normal ALT [J].
Sarin, SK ;
Sandhu, BS ;
Sharma, BC ;
Jain, M ;
Singh, J ;
Malhotra, V .
JOURNAL OF VIRAL HEPATITIS, 2004, 11 (06) :552-558
[29]   B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy [J].
Selenko-Gebauer, N ;
Majdic, O ;
Szekeres, A ;
Höfler, G ;
Guthann, E ;
Korthäuer, U ;
Zlabinger, G ;
Steinberger, P ;
Pickl, WF ;
Stockinger, H ;
Knapp, W ;
Stöckl, J .
JOURNAL OF IMMUNOLOGY, 2003, 170 (07) :3637-3644
[30]   The B7-CD28 superfamily [J].
Sharpe, AH ;
Freeman, GJ .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (02) :116-126